Aster DM Healthcare reported a strong financial performance for the third quarter (Q3) and nine months (9M) of FY25, driven by higher patient volumes and operational efficiency.
The company’s revenue for 9M FY25 rose 15% year-on-year (YoY) to Rs 3,138 crore, while its operating EBITDA surged 35% YoY to Rs 613 crore. Q3 FY25 revenue grew 11% YoY to Rs 1,050 crore, with operating EBITDA increasing by 20% YoY to Rs 202 crore. The operating EBITDA margin improved to 19.5% in 9M FY25 from 16.6% in 9M FY24.
The revenue increased by 15% YoY to Rs 3,138 crore in 9M FY25, up from Rs 2,721 crore in 9M FY24. In Q3 FY25, revenue grew by 11% YoY, reaching Rs 1,050 crore compared to Rs 949 crore in Q3 FY24.
Profit before tax (PBT) jumped 103% YoY to Rs 413 crore in 9M FY25, while adjusted net profit (post NCI) increased 65% YoY to Rs 251 crore. The board approved an interim dividend of Rs 4 per equity share.
Dr. Azad Moopen, Founder and Chairman of Aster DM Healthcare, highlighted the company’s focus on operational excellence and expansion, with plans to exceed 6,800 beds by FY27.
Published: 03 Feb 2025, 10:00 pm IST
Related Topics
Subscribe to our Newsletter
Disclaimer: Kindly avoid objectionable, derogatory, unlawful and lewd comments, while responding to reports. Such comments are punishable under cyber laws. Please keep away from personal attacks. The opinions expressed here are the personal opinions of readers and not that of Mathrubhumi.
